Trending Now
Calithera Biosciences Inc. (NASDAQ:CALA) Commences KEAPSAKE Phase 2 Study Of Telaglenastat...
Calithera Biosciences Inc. (NASDAQ:CALA) has announced the dosing of the first patient in its randomized second phases non-small cell lung cancer glutaminase inhibitor telaglenastat...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Nova Mentis Life Science Corp (OTCMKTS: NMLSF) to File for a...
Nova Mentis Life Science Corp wants to develop wide-ranging substances. They include tryptamine analogues, psilocybin, aeruginascin, and baeocystin. It seems to have made a significant...
MAKE IT MODERN
LATEST REVIEWS
BioNTech Se (NASDAQ:BNTX) And EIB Sign €100 Million Financing Agreement for...
BioNTech Se (NASDAQ:BNTX) and the European Investment Banks (EIB) have finalized a debt financing agreement of €100 million to support the development of the...
MAKE IT MODERN
PERFORMANCE TRAINING
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) Enters Co-Promotion Partnership Deal For Probuphine Implant With Indegene
Titan Pharmaceuticals Inc. (NASDAQ:TTNP) has announced that it has signed a co-promotion partnership agreement with Indegene Inc. The partnership is meant to establish multichannel...
Clinical Trial of Experimental Ulcerative Colitis Drug Humming Along
Investors generally expect clinical trials to take a long time. That’s not always the case. Take Innovation Pharmaceuticals (OTCQB:IPIX), for example. Looking...
Travere Therapeutics (TVTX) Stock Gains Amid Positive Novartis Data and Calliditas Buyout News
Travere Therapeutics (NASDAQ: TVTX) experienced a notable increase in its stock price following two significant developments: positive data from Novartis and rumors...
Adial Pharmaceuticals Inc. (NASDAQ:ADIL) Receives Approval For ONWARD Study, To Use COVID-19 Rapid Result...
Adial Pharmaceuticals Inc. (NASDAQ:ADIL) has announced that its breakthrough ONWARD pivotal third phase clinical study in Poland has received approval for the evaluation of...
Geopolitical Tensions Fuel Oil Price Surge Amid Middle East Unrest
Oil prices saw an increase at the start of the week, influenced by geopolitical tensions. This rise followed a significant incident over...
MAKE IT MODERN
